- Home
- TRUP vs EWTX Comparison
TRUP vs EWTX Comparison
Compare TRUP & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUP
- EWTX
- Stock Information
- Founded
- TRUP 2000
- EWTX 2017
- Country
- TRUP United States
- EWTX United States
- Employees
- TRUP N/A
- EWTX N/A
- Industry
- TRUP Medical Specialities
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- TRUP Health Care
- EWTX Health Care
- Exchange
- TRUP Nasdaq
- EWTX Nasdaq
- Market Cap
- TRUP 1.4B
- EWTX 2.7B
- IPO Year
- TRUP 2014
- EWTX 2021
- Fundamental
- Price
- TRUP $33.58
- EWTX $25.28
- Analyst Decision
- TRUP Buy
- EWTX Buy
- Analyst Count
- TRUP 6
- EWTX 8
- Target Price
- TRUP $46.60
- EWTX $45.38
- AVG Volume (30 Days)
- TRUP 943.1K
- EWTX 1.3M
- Earning Date
- TRUP 05-01-2025
- EWTX 03-03-2025
- Dividend Yield
- TRUP N/A
- EWTX N/A
- EPS Growth
- TRUP N/A
- EWTX N/A
- EPS
- TRUP N/A
- EWTX N/A
- Revenue
- TRUP $1,285,684,000.00
- EWTX N/A
- Revenue This Year
- TRUP N/A
- EWTX N/A
- Revenue Next Year
- TRUP $5.05
- EWTX N/A
- P/E Ratio
- TRUP N/A
- EWTX N/A
- Revenue Growth
- TRUP 15.97
- EWTX N/A
- 52 Week Low
- TRUP $19.69
- EWTX $14.90
- 52 Week High
- TRUP $57.90
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- TRUP 35.59
- EWTX 43.18
- Support Level
- TRUP $31.76
- EWTX $24.22
- Resistance Level
- TRUP $34.65
- EWTX $28.51
- Average True Range (ATR)
- TRUP 1.89
- EWTX 2.14
- MACD
- TRUP 0.25
- EWTX 0.02
- Stochastic Oscillator
- TRUP 61.67
- EWTX 27.55
Stock Price Comparison Chart: TRUP vs EWTX
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.